Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v1-EN
Language English English
Date Updated 2020-04-25 2020-03-02
Drug Identification Number 02241094 02241094
Brand name TEMODAL TEMODAL
Common or Proper name temozolomide capsules temozolomide capsules
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients TEMOZOLOMIDE TEMOZOLOMIDE
Strength(s) 20MG 20MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 5CAP 5CAP
ATC code L01AX L01AX
ATC description ALKYLATINGAGENTS ALKYLATINGAGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-03-20 2020-03-20
Actual start date 2020-03-17
Estimated end date 2020-04-30 2020-04-24
Actual end date 2020-04-24
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments